nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Anaphylactic shock—Vincristine—hematologic cancer	0.00166	0.00166	CcSEcCtD
Metaxalone—Dizziness—Imatinib—hematologic cancer	0.00165	0.00165	CcSEcCtD
Metaxalone—Hypersensitivity—Melphalan—hematologic cancer	0.00165	0.00165	CcSEcCtD
Metaxalone—Nausea—Procarbazine—hematologic cancer	0.00165	0.00165	CcSEcCtD
Metaxalone—Vomiting—Chlorambucil—hematologic cancer	0.00163	0.00163	CcSEcCtD
Metaxalone—Dizziness—Cladribine—hematologic cancer	0.00162	0.00162	CcSEcCtD
Metaxalone—Nausea—Dasatinib—hematologic cancer	0.00162	0.00162	CcSEcCtD
Metaxalone—Nausea—Bexarotene—hematologic cancer	0.00162	0.00162	CcSEcCtD
Metaxalone—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.00161	0.00161	CcSEcCtD
Metaxalone—Anaphylactic shock—Irinotecan—hematologic cancer	0.00161	0.00161	CcSEcCtD
Metaxalone—Nausea—Fludarabine—hematologic cancer	0.00161	0.00161	CcSEcCtD
Metaxalone—Leukopenia—Cisplatin—hematologic cancer	0.00161	0.00161	CcSEcCtD
Metaxalone—Somnolence—Thalidomide—hematologic cancer	0.00161	0.00161	CcSEcCtD
Metaxalone—Hypersensitivity—Lenalidomide—hematologic cancer	0.0016	0.0016	CcSEcCtD
Metaxalone—Vomiting—Nilotinib—hematologic cancer	0.0016	0.0016	CcSEcCtD
Metaxalone—Vomiting—Imatinib—hematologic cancer	0.00159	0.00159	CcSEcCtD
Metaxalone—Pruritus—Melphalan—hematologic cancer	0.00158	0.00158	CcSEcCtD
Metaxalone—Rash—Nilotinib—hematologic cancer	0.00158	0.00158	CcSEcCtD
Metaxalone—Dermatitis—Nilotinib—hematologic cancer	0.00158	0.00158	CcSEcCtD
Metaxalone—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00158	0.00158	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.00158	0.00158	CcSEcCtD
Metaxalone—Rash—Imatinib—hematologic cancer	0.00158	0.00158	CcSEcCtD
Metaxalone—Headache—Nilotinib—hematologic cancer	0.00157	0.00157	CcSEcCtD
Metaxalone—Dermatitis—Imatinib—hematologic cancer	0.00157	0.00157	CcSEcCtD
Metaxalone—Anaphylactic shock—Gemcitabine—hematologic cancer	0.00157	0.00157	CcSEcCtD
Metaxalone—Headache—Imatinib—hematologic cancer	0.00157	0.00157	CcSEcCtD
Metaxalone—Irritability—Methotrexate—hematologic cancer	0.00156	0.00156	CcSEcCtD
Metaxalone—Vomiting—Cladribine—hematologic cancer	0.00156	0.00156	CcSEcCtD
Metaxalone—Dizziness—Vinblastine—hematologic cancer	0.00156	0.00156	CcSEcCtD
Metaxalone—Rash—Cladribine—hematologic cancer	0.00155	0.00155	CcSEcCtD
Metaxalone—Dermatitis—Cladribine—hematologic cancer	0.00155	0.00155	CcSEcCtD
Metaxalone—Somnolence—Carmustine—hematologic cancer	0.00154	0.00154	CcSEcCtD
Metaxalone—Pruritus—Lenalidomide—hematologic cancer	0.00154	0.00154	CcSEcCtD
Metaxalone—Headache—Cladribine—hematologic cancer	0.00154	0.00154	CcSEcCtD
Metaxalone—Somnolence—Alitretinoin—hematologic cancer	0.00153	0.00153	CcSEcCtD
Metaxalone—Nausea—Chlorambucil—hematologic cancer	0.00153	0.00153	CcSEcCtD
Metaxalone—Somnolence—Ifosfamide—hematologic cancer	0.00151	0.00151	CcSEcCtD
Metaxalone—Vomiting—Vinblastine—hematologic cancer	0.0015	0.0015	CcSEcCtD
Metaxalone—Nausea—Nilotinib—hematologic cancer	0.00149	0.00149	CcSEcCtD
Metaxalone—Nausea—Imatinib—hematologic cancer	0.00148	0.00148	CcSEcCtD
Metaxalone—Hypersensitivity—Bortezomib—hematologic cancer	0.00148	0.00148	CcSEcCtD
Metaxalone—Headache—Vinblastine—hematologic cancer	0.00148	0.00148	CcSEcCtD
Metaxalone—Leukopenia—Etoposide—hematologic cancer	0.00147	0.00147	CcSEcCtD
Metaxalone—Anaphylactic shock—Cisplatin—hematologic cancer	0.00147	0.00147	CcSEcCtD
Metaxalone—Hypersensitivity—Bleomycin—hematologic cancer	0.00147	0.00147	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.00146	0.00146	CcSEcCtD
Metaxalone—Nausea—Cladribine—hematologic cancer	0.00146	0.00146	CcSEcCtD
Metaxalone—Hypersensitivity—Vinorelbine—hematologic cancer	0.00144	0.00144	CcSEcCtD
Metaxalone—Dizziness—Lenalidomide—hematologic cancer	0.00144	0.00144	CcSEcCtD
Metaxalone—Somnolence—Irinotecan—hematologic cancer	0.00143	0.00143	CcSEcCtD
Metaxalone—Somnolence—Mitoxantrone—hematologic cancer	0.00143	0.00143	CcSEcCtD
Metaxalone—Vomiting—Melphalan—hematologic cancer	0.00142	0.00142	CcSEcCtD
Metaxalone—Dizziness—Hydroxyurea—hematologic cancer	0.00142	0.00142	CcSEcCtD
Metaxalone—Pruritus—Bortezomib—hematologic cancer	0.00142	0.00142	CcSEcCtD
Metaxalone—Rash—Melphalan—hematologic cancer	0.00141	0.00141	CcSEcCtD
Metaxalone—Dermatitis—Melphalan—hematologic cancer	0.00141	0.00141	CcSEcCtD
Metaxalone—Pruritus—Bleomycin—hematologic cancer	0.00141	0.00141	CcSEcCtD
Metaxalone—Nausea—Vinblastine—hematologic cancer	0.0014	0.0014	CcSEcCtD
Metaxalone—Somnolence—Gemcitabine—hematologic cancer	0.0014	0.0014	CcSEcCtD
Metaxalone—Vomiting—Lenalidomide—hematologic cancer	0.00138	0.00138	CcSEcCtD
Metaxalone—Pruritus—Vinorelbine—hematologic cancer	0.00138	0.00138	CcSEcCtD
Metaxalone—Hypersensitivity—Thiotepa—hematologic cancer	0.00138	0.00138	CcSEcCtD
Metaxalone—Rash—Lenalidomide—hematologic cancer	0.00137	0.00137	CcSEcCtD
Metaxalone—Dermatitis—Lenalidomide—hematologic cancer	0.00137	0.00137	CcSEcCtD
Metaxalone—Vomiting—Hydroxyurea—hematologic cancer	0.00137	0.00137	CcSEcCtD
Metaxalone—Headache—Lenalidomide—hematologic cancer	0.00136	0.00136	CcSEcCtD
Metaxalone—Abdominal discomfort—Methotrexate—hematologic cancer	0.00136	0.00136	CcSEcCtD
Metaxalone—Rash—Hydroxyurea—hematologic cancer	0.00135	0.00135	CcSEcCtD
Metaxalone—Dermatitis—Hydroxyurea—hematologic cancer	0.00135	0.00135	CcSEcCtD
Metaxalone—Headache—Hydroxyurea—hematologic cancer	0.00135	0.00135	CcSEcCtD
Metaxalone—Anaphylactic shock—Etoposide—hematologic cancer	0.00134	0.00134	CcSEcCtD
Metaxalone—Hypersensitivity—Thalidomide—hematologic cancer	0.00133	0.00133	CcSEcCtD
Metaxalone—Nausea—Melphalan—hematologic cancer	0.00133	0.00133	CcSEcCtD
Metaxalone—Dizziness—Bortezomib—hematologic cancer	0.00133	0.00133	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisolone—hematologic cancer	0.00132	0.00132	CcSEcCtD
Metaxalone—Pruritus—Thiotepa—hematologic cancer	0.00132	0.00132	CcSEcCtD
Metaxalone—Dizziness—Vinorelbine—hematologic cancer	0.00129	0.00129	CcSEcCtD
Metaxalone—Nausea—Lenalidomide—hematologic cancer	0.00129	0.00129	CcSEcCtD
Metaxalone—Hypersensitivity—Carmustine—hematologic cancer	0.00128	0.00128	CcSEcCtD
Metaxalone—Pruritus—Thalidomide—hematologic cancer	0.00128	0.00128	CcSEcCtD
Metaxalone—Nausea—Hydroxyurea—hematologic cancer	0.00128	0.00128	CcSEcCtD
Metaxalone—Vomiting—Bortezomib—hematologic cancer	0.00127	0.00127	CcSEcCtD
Metaxalone—Hypersensitivity—Alitretinoin—hematologic cancer	0.00127	0.00127	CcSEcCtD
Metaxalone—Vomiting—Bleomycin—hematologic cancer	0.00126	0.00126	CcSEcCtD
Metaxalone—Rash—Bortezomib—hematologic cancer	0.00126	0.00126	CcSEcCtD
Metaxalone—Dermatitis—Bortezomib—hematologic cancer	0.00126	0.00126	CcSEcCtD
Metaxalone—Drowsiness—Methotrexate—hematologic cancer	0.00126	0.00126	CcSEcCtD
Metaxalone—Headache—Bortezomib—hematologic cancer	0.00126	0.00126	CcSEcCtD
Metaxalone—Rash—Bleomycin—hematologic cancer	0.00125	0.00125	CcSEcCtD
Metaxalone—Dermatitis—Bleomycin—hematologic cancer	0.00125	0.00125	CcSEcCtD
Metaxalone—Hypersensitivity—Ifosfamide—hematologic cancer	0.00125	0.00125	CcSEcCtD
Metaxalone—Vomiting—Vinorelbine—hematologic cancer	0.00124	0.00124	CcSEcCtD
Metaxalone—Dizziness—Thiotepa—hematologic cancer	0.00124	0.00124	CcSEcCtD
Metaxalone—Rash—Vinorelbine—hematologic cancer	0.00123	0.00123	CcSEcCtD
Metaxalone—Dermatitis—Vinorelbine—hematologic cancer	0.00123	0.00123	CcSEcCtD
Metaxalone—Headache—Vinorelbine—hematologic cancer	0.00123	0.00123	CcSEcCtD
Metaxalone—Hypersensitivity—Vincristine—hematologic cancer	0.00122	0.00122	CcSEcCtD
Metaxalone—Anaphylactic shock—Triamcinolone—hematologic cancer	0.00122	0.00122	CcSEcCtD
Metaxalone—Pruritus—Alitretinoin—hematologic cancer	0.00122	0.00122	CcSEcCtD
Metaxalone—Pruritus—Ifosfamide—hematologic cancer	0.0012	0.0012	CcSEcCtD
Metaxalone—Dizziness—Thalidomide—hematologic cancer	0.0012	0.0012	CcSEcCtD
Metaxalone—Somnolence—Etoposide—hematologic cancer	0.00119	0.00119	CcSEcCtD
Metaxalone—Nausea—Bortezomib—hematologic cancer	0.00119	0.00119	CcSEcCtD
Metaxalone—Hypersensitivity—Irinotecan—hematologic cancer	0.00119	0.00119	CcSEcCtD
Metaxalone—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00119	0.00119	CcSEcCtD
Metaxalone—Vomiting—Thiotepa—hematologic cancer	0.00119	0.00119	CcSEcCtD
Metaxalone—Nausea—Bleomycin—hematologic cancer	0.00118	0.00118	CcSEcCtD
Metaxalone—Drowsiness—Epirubicin—hematologic cancer	0.00118	0.00118	CcSEcCtD
Metaxalone—Rash—Thiotepa—hematologic cancer	0.00118	0.00118	CcSEcCtD
Metaxalone—Dermatitis—Thiotepa—hematologic cancer	0.00118	0.00118	CcSEcCtD
Metaxalone—Headache—Thiotepa—hematologic cancer	0.00117	0.00117	CcSEcCtD
Metaxalone—Nausea—Vinorelbine—hematologic cancer	0.00116	0.00116	CcSEcCtD
Metaxalone—Jaundice—Epirubicin—hematologic cancer	0.00115	0.00115	CcSEcCtD
Metaxalone—Vomiting—Thalidomide—hematologic cancer	0.00115	0.00115	CcSEcCtD
Metaxalone—Dizziness—Carmustine—hematologic cancer	0.00115	0.00115	CcSEcCtD
Metaxalone—Rash—Thalidomide—hematologic cancer	0.00114	0.00114	CcSEcCtD
Metaxalone—Dermatitis—Thalidomide—hematologic cancer	0.00114	0.00114	CcSEcCtD
Metaxalone—Dizziness—Alitretinoin—hematologic cancer	0.00114	0.00114	CcSEcCtD
Metaxalone—Headache—Thalidomide—hematologic cancer	0.00113	0.00113	CcSEcCtD
Metaxalone—Dizziness—Ifosfamide—hematologic cancer	0.00112	0.00112	CcSEcCtD
Metaxalone—Pruritus—Gemcitabine—hematologic cancer	0.00111	0.00111	CcSEcCtD
Metaxalone—Nausea—Thiotepa—hematologic cancer	0.00111	0.00111	CcSEcCtD
Metaxalone—Anaphylactic shock—Betamethasone—hematologic cancer	0.0011	0.0011	CcSEcCtD
Metaxalone—Anaphylactic shock—Dexamethasone—hematologic cancer	0.0011	0.0011	CcSEcCtD
Metaxalone—Vomiting—Carmustine—hematologic cancer	0.0011	0.0011	CcSEcCtD
Metaxalone—Dizziness—Vincristine—hematologic cancer	0.0011	0.0011	CcSEcCtD
Metaxalone—Rash—Carmustine—hematologic cancer	0.00109	0.00109	CcSEcCtD
Metaxalone—Dermatitis—Carmustine—hematologic cancer	0.00109	0.00109	CcSEcCtD
Metaxalone—Vomiting—Alitretinoin—hematologic cancer	0.00109	0.00109	CcSEcCtD
Metaxalone—Drowsiness—Doxorubicin—hematologic cancer	0.00109	0.00109	CcSEcCtD
Metaxalone—Headache—Carmustine—hematologic cancer	0.00109	0.00109	CcSEcCtD
Metaxalone—Rash—Alitretinoin—hematologic cancer	0.00108	0.00108	CcSEcCtD
Metaxalone—Dermatitis—Alitretinoin—hematologic cancer	0.00108	0.00108	CcSEcCtD
Metaxalone—Vomiting—Ifosfamide—hematologic cancer	0.00108	0.00108	CcSEcCtD
Metaxalone—Hypersensitivity—Cisplatin—hematologic cancer	0.00108	0.00108	CcSEcCtD
Metaxalone—Headache—Alitretinoin—hematologic cancer	0.00108	0.00108	CcSEcCtD
Metaxalone—Nausea—Thalidomide—hematologic cancer	0.00107	0.00107	CcSEcCtD
Metaxalone—Rash—Ifosfamide—hematologic cancer	0.00107	0.00107	CcSEcCtD
Metaxalone—Dermatitis—Ifosfamide—hematologic cancer	0.00107	0.00107	CcSEcCtD
Metaxalone—Dizziness—Irinotecan—hematologic cancer	0.00107	0.00107	CcSEcCtD
Metaxalone—Jaundice—Doxorubicin—hematologic cancer	0.00106	0.00106	CcSEcCtD
Metaxalone—Vomiting—Vincristine—hematologic cancer	0.00105	0.00105	CcSEcCtD
Metaxalone—Rash—Vincristine—hematologic cancer	0.00104	0.00104	CcSEcCtD
Metaxalone—Dermatitis—Vincristine—hematologic cancer	0.00104	0.00104	CcSEcCtD
Metaxalone—Headache—Vincristine—hematologic cancer	0.00104	0.00104	CcSEcCtD
Metaxalone—Nausea—Carmustine—hematologic cancer	0.00103	0.00103	CcSEcCtD
Metaxalone—Vomiting—Mitoxantrone—hematologic cancer	0.00103	0.00103	CcSEcCtD
Metaxalone—Vomiting—Irinotecan—hematologic cancer	0.00103	0.00103	CcSEcCtD
Metaxalone—Nausea—Alitretinoin—hematologic cancer	0.00102	0.00102	CcSEcCtD
Metaxalone—Rash—Mitoxantrone—hematologic cancer	0.00102	0.00102	CcSEcCtD
Metaxalone—Rash—Irinotecan—hematologic cancer	0.00102	0.00102	CcSEcCtD
Metaxalone—Dermatitis—Irinotecan—hematologic cancer	0.00102	0.00102	CcSEcCtD
Metaxalone—Dermatitis—Mitoxantrone—hematologic cancer	0.00102	0.00102	CcSEcCtD
Metaxalone—Headache—Mitoxantrone—hematologic cancer	0.00101	0.00101	CcSEcCtD
Metaxalone—Headache—Irinotecan—hematologic cancer	0.00101	0.00101	CcSEcCtD
Metaxalone—Nausea—Ifosfamide—hematologic cancer	0.00101	0.00101	CcSEcCtD
Metaxalone—Vomiting—Gemcitabine—hematologic cancer	0.001	0.001	CcSEcCtD
Metaxalone—Rash—Gemcitabine—hematologic cancer	0.000991	0.000991	CcSEcCtD
Metaxalone—Dermatitis—Gemcitabine—hematologic cancer	0.00099	0.00099	CcSEcCtD
Metaxalone—Hypersensitivity—Etoposide—hematologic cancer	0.000989	0.000989	CcSEcCtD
Metaxalone—Headache—Gemcitabine—hematologic cancer	0.000985	0.000985	CcSEcCtD
Metaxalone—Nausea—Vincristine—hematologic cancer	0.000984	0.000984	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisolone—hematologic cancer	0.000976	0.000976	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisone—hematologic cancer	0.000962	0.000962	CcSEcCtD
Metaxalone—Nausea—Irinotecan—hematologic cancer	0.000959	0.000959	CcSEcCtD
Metaxalone—Nausea—Mitoxantrone—hematologic cancer	0.000959	0.000959	CcSEcCtD
Metaxalone—Pruritus—Etoposide—hematologic cancer	0.00095	0.00095	CcSEcCtD
Metaxalone—Nausea—Gemcitabine—hematologic cancer	0.000934	0.000934	CcSEcCtD
Metaxalone—Vomiting—Cisplatin—hematologic cancer	0.000932	0.000932	CcSEcCtD
Metaxalone—Rash—Cisplatin—hematologic cancer	0.000924	0.000924	CcSEcCtD
Metaxalone—Dermatitis—Cisplatin—hematologic cancer	0.000923	0.000923	CcSEcCtD
Metaxalone—Tension—Epirubicin—hematologic cancer	0.000905	0.000905	CcSEcCtD
Metaxalone—Hypersensitivity—Triamcinolone—hematologic cancer	0.000897	0.000897	CcSEcCtD
Metaxalone—Nervousness—Epirubicin—hematologic cancer	0.000896	0.000896	CcSEcCtD
Metaxalone—Dizziness—Etoposide—hematologic cancer	0.000888	0.000888	CcSEcCtD
Metaxalone—Leukopenia—Methotrexate—hematologic cancer	0.000882	0.000882	CcSEcCtD
Metaxalone—Dizziness—Prednisolone—hematologic cancer	0.000876	0.000876	CcSEcCtD
Metaxalone—Nausea—Cisplatin—hematologic cancer	0.00087	0.00087	CcSEcCtD
Metaxalone—Pruritus—Triamcinolone—hematologic cancer	0.000861	0.000861	CcSEcCtD
Metaxalone—Vomiting—Etoposide—hematologic cancer	0.000854	0.000854	CcSEcCtD
Metaxalone—Rash—Etoposide—hematologic cancer	0.000846	0.000846	CcSEcCtD
Metaxalone—Dermatitis—Etoposide—hematologic cancer	0.000846	0.000846	CcSEcCtD
Metaxalone—Headache—Etoposide—hematologic cancer	0.000841	0.000841	CcSEcCtD
Metaxalone—Tension—Doxorubicin—hematologic cancer	0.000837	0.000837	CcSEcCtD
Metaxalone—Rash—Prednisolone—hematologic cancer	0.000835	0.000835	CcSEcCtD
Metaxalone—Dermatitis—Prednisolone—hematologic cancer	0.000834	0.000834	CcSEcCtD
Metaxalone—Headache—Prednisolone—hematologic cancer	0.000829	0.000829	CcSEcCtD
Metaxalone—Nervousness—Doxorubicin—hematologic cancer	0.000829	0.000829	CcSEcCtD
Metaxalone—Leukopenia—Epirubicin—hematologic cancer	0.000825	0.000825	CcSEcCtD
Metaxalone—Dizziness—Triamcinolone—hematologic cancer	0.000805	0.000805	CcSEcCtD
Metaxalone—Anaphylactic shock—Methotrexate—hematologic cancer	0.000804	0.000804	CcSEcCtD
Metaxalone—Nausea—Etoposide—hematologic cancer	0.000797	0.000797	CcSEcCtD
Metaxalone—Nausea—Prednisolone—hematologic cancer	0.000786	0.000786	CcSEcCtD
Metaxalone—Pruritus—Dexamethasone—hematologic cancer	0.000782	0.000782	CcSEcCtD
Metaxalone—Pruritus—Betamethasone—hematologic cancer	0.000782	0.000782	CcSEcCtD
Metaxalone—Vomiting—Triamcinolone—hematologic cancer	0.000774	0.000774	CcSEcCtD
Metaxalone—Rash—Triamcinolone—hematologic cancer	0.000768	0.000768	CcSEcCtD
Metaxalone—Dermatitis—Triamcinolone—hematologic cancer	0.000767	0.000767	CcSEcCtD
Metaxalone—Leukopenia—Doxorubicin—hematologic cancer	0.000764	0.000764	CcSEcCtD
Metaxalone—Headache—Triamcinolone—hematologic cancer	0.000763	0.000763	CcSEcCtD
Metaxalone—Anaphylactic shock—Epirubicin—hematologic cancer	0.000753	0.000753	CcSEcCtD
Metaxalone—Dizziness—Dexamethasone—hematologic cancer	0.000731	0.000731	CcSEcCtD
Metaxalone—Dizziness—Betamethasone—hematologic cancer	0.000731	0.000731	CcSEcCtD
Metaxalone—Nausea—Triamcinolone—hematologic cancer	0.000723	0.000723	CcSEcCtD
Metaxalone—Somnolence—Methotrexate—hematologic cancer	0.000715	0.000715	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisone—hematologic cancer	0.000709	0.000709	CcSEcCtD
Metaxalone—Vomiting—Betamethasone—hematologic cancer	0.000702	0.000702	CcSEcCtD
Metaxalone—Vomiting—Dexamethasone—hematologic cancer	0.000702	0.000702	CcSEcCtD
Metaxalone—Rash—Dexamethasone—hematologic cancer	0.000697	0.000697	CcSEcCtD
Metaxalone—Rash—Betamethasone—hematologic cancer	0.000697	0.000697	CcSEcCtD
Metaxalone—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000696	0.000696	CcSEcCtD
Metaxalone—Dermatitis—Betamethasone—hematologic cancer	0.000696	0.000696	CcSEcCtD
Metaxalone—Dermatitis—Dexamethasone—hematologic cancer	0.000696	0.000696	CcSEcCtD
Metaxalone—Headache—Betamethasone—hematologic cancer	0.000692	0.000692	CcSEcCtD
Metaxalone—Headache—Dexamethasone—hematologic cancer	0.000692	0.000692	CcSEcCtD
Metaxalone—Pruritus—Prednisone—hematologic cancer	0.000681	0.000681	CcSEcCtD
Metaxalone—Somnolence—Epirubicin—hematologic cancer	0.000669	0.000669	CcSEcCtD
Metaxalone—Nausea—Betamethasone—hematologic cancer	0.000656	0.000656	CcSEcCtD
Metaxalone—Nausea—Dexamethasone—hematologic cancer	0.000656	0.000656	CcSEcCtD
Metaxalone—Dizziness—Prednisone—hematologic cancer	0.000636	0.000636	CcSEcCtD
Metaxalone—Somnolence—Doxorubicin—hematologic cancer	0.000619	0.000619	CcSEcCtD
Metaxalone—Vomiting—Prednisone—hematologic cancer	0.000612	0.000612	CcSEcCtD
Metaxalone—Rash—Prednisone—hematologic cancer	0.000607	0.000607	CcSEcCtD
Metaxalone—Dermatitis—Prednisone—hematologic cancer	0.000606	0.000606	CcSEcCtD
Metaxalone—Headache—Prednisone—hematologic cancer	0.000603	0.000603	CcSEcCtD
Metaxalone—Hypersensitivity—Methotrexate—hematologic cancer	0.000592	0.000592	CcSEcCtD
Metaxalone—Nausea—Prednisone—hematologic cancer	0.000572	0.000572	CcSEcCtD
Metaxalone—Pruritus—Methotrexate—hematologic cancer	0.000569	0.000569	CcSEcCtD
Metaxalone—Hypersensitivity—Epirubicin—hematologic cancer	0.000554	0.000554	CcSEcCtD
Metaxalone—Pruritus—Epirubicin—hematologic cancer	0.000532	0.000532	CcSEcCtD
Metaxalone—Dizziness—Methotrexate—hematologic cancer	0.000532	0.000532	CcSEcCtD
Metaxalone—Hypersensitivity—Doxorubicin—hematologic cancer	0.000513	0.000513	CcSEcCtD
Metaxalone—Vomiting—Methotrexate—hematologic cancer	0.000511	0.000511	CcSEcCtD
Metaxalone—Rash—Methotrexate—hematologic cancer	0.000507	0.000507	CcSEcCtD
Metaxalone—Dermatitis—Methotrexate—hematologic cancer	0.000507	0.000507	CcSEcCtD
Metaxalone—Headache—Methotrexate—hematologic cancer	0.000504	0.000504	CcSEcCtD
Metaxalone—Dizziness—Epirubicin—hematologic cancer	0.000498	0.000498	CcSEcCtD
Metaxalone—Pruritus—Doxorubicin—hematologic cancer	0.000493	0.000493	CcSEcCtD
Metaxalone—Vomiting—Epirubicin—hematologic cancer	0.000478	0.000478	CcSEcCtD
Metaxalone—Nausea—Methotrexate—hematologic cancer	0.000478	0.000478	CcSEcCtD
Metaxalone—Rash—Epirubicin—hematologic cancer	0.000474	0.000474	CcSEcCtD
Metaxalone—Dermatitis—Epirubicin—hematologic cancer	0.000474	0.000474	CcSEcCtD
Metaxalone—Headache—Epirubicin—hematologic cancer	0.000471	0.000471	CcSEcCtD
Metaxalone—Dizziness—Doxorubicin—hematologic cancer	0.00046	0.00046	CcSEcCtD
Metaxalone—Nausea—Epirubicin—hematologic cancer	0.000447	0.000447	CcSEcCtD
Metaxalone—Vomiting—Doxorubicin—hematologic cancer	0.000443	0.000443	CcSEcCtD
Metaxalone—Rash—Doxorubicin—hematologic cancer	0.000439	0.000439	CcSEcCtD
Metaxalone—Dermatitis—Doxorubicin—hematologic cancer	0.000439	0.000439	CcSEcCtD
Metaxalone—Headache—Doxorubicin—hematologic cancer	0.000436	0.000436	CcSEcCtD
Metaxalone—Nausea—Doxorubicin—hematologic cancer	0.000414	0.000414	CcSEcCtD
